Lam Research (LRCX) Q1 2027 Earnings Call Transcript

Lam Research reported September-quarter revenue of $8.22 billion, up 22% sequentially and 54% year over year, with record non-GAAP gross margin of 52.4%, operating margin of 40.2%, and diluted EPS of $2.20. It guided December-quarter revenue to $8.6 billion ± $400 million and EPS to $2.33 ± $0.15; management said near-term supply constraints kept the revenue outlook somewhat lower. Lam forecast 2026 WFE spending in the mid-$150 billion range and gave a preliminary 2027 outlook above $200 billion, citing AI-driven demand while noting clean-room and component-supply constraints.

Analysis

The key distinction is between durable end demand and near-term revenue conversion. Management’s capacity constraints may defer shipments into later quarters, but they also expose a second risk: customer clean-room schedules, component availability, and Lam’s own hiring ramp must all align before stated demand becomes recognized revenue. Treat the 2027 WFE outlook as a demand signal—not a guaranteed shipment forecast—and reassess at the January update.

Lam’s strongest potential differentiator is rising etch/deposition intensity across multiple architectures, not any single AI-linked product claim. That could support outperformance versus broader equipment peers such as Applied Materials and Tokyo Electron. However, the proposed SLC NAND capacity effect remains a customer-adoption scenario, not bankable demand until mix shifts and fab plans are confirmed. Advanced packaging and service contracts offer longer-duration support; CSBG may cushion a systems slowdown, although exceptionally strong utilization and upgrade activity could normalize.

Near term, China’s lower expected revenue contribution can create an unfavorable mix/comparison headline even if non-China demand holds up. Model the higher tax rate separately from operating performance. Record margins also raise the bar: labor, supplier costs, or less favorable product mix could limit incremental operating leverage. The company’s growth and product-performance assertions warrant validation against shipment trends, customer adoption, and subsequent guidance rather than being treated as independently verified.

Over 6–18 months, the bull case is continued WFE growth plus Lam gaining share in process-intensive nodes and packaging. The bear case is demand exceeding installable capacity for longer than expected, pushing revenue out while expectations outrun execution. Watch China mix, gross-margin direction, deferred revenue, and the January 2027 WFE/supply-chain update.

Key Decisions for Investors

• Consider a staged long in LRCX on post-earnings volatility or a pullback, rather than chasing an initial gap higher. The thesis is differentiated process intensity plus potential share gains; the main risk is that supply and clean-room constraints delay conversion of demand into shipments.
• For a relative-value expression, pair a measured LRCX long with a short in a diversified semiconductor-equipment basket. This targets Lam-specific outperformance while reducing broad WFE-cycle exposure; reduce or exit if Lam’s guidance or margins weaken relative to peers.
• Use the January 2027 outlook as the next confirmation point. Upgrade conviction only if the WFE outlook firms and delivery constraints ease; falsify the thesis if guidance is cut, deferred revenue weakens, or gross margin deteriorates beyond mix-related fluctuation.
• Treat SLC NAND and panel-level packaging as watch items, not near-term earnings underwrites. Seek confirmation in customer capacity plans, production adoption, and Lam’s disclosed revenue contribution before assigning material incremental value.